Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

PD-1/PD-L1-IN 6

SKU: orb1688070

Description

PD-1/PD-L1-IN 6 (Compound A13) is a potent small molecule inhibitor of the PD-1/PD-L1 immune checkpoint, exhibiting an IC50 of 132.8 nM. It demonstrates significant immunoregulatory activity in vitro, restoring T-cell function and enhancing interferon-γ secretion in co-culture models without significant cytotoxicity, supporting its use in immuno-oncology research.

Research Area

Cancer Biology; Immunology & Inflammation, Cell Biology, Immunology & Inflammation

Images & Validation

Key Properties

CAS Number2393983-76-9
MW402.49
FormulaC25H26N2O3
SMILESC(=O)(N1C=2C(=C(C=CC2)C3=CC=CC=C3)CC1)C4=CC(OC)=C(CNCCO)C=C4
TargetOthers,PD-1/PD-L1

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • INCB086550 [orb1693347]

    98.49% (May vary between batches)

    2230911-59-6

    693.79

    C41H39N7O4

    50 mg, 1 mg, 5 mg, 10 mg, 25 mg, 100 mg
  • PD-1/PD-L1-IN-30 [orb1744712]

    2171558-14-6

    527.53

    C29H28F3NO5

    50 mg, 100 mg, 25 mg
  • PD-1/PD-L1-IN-13 [orb1744751]

    726.12

    C36H34ClF2N3O9

    25 mg, 50 mg, 100 mg
  • PD-1/PD-L1-IN-26 [orb1744753]

    2966090-78-6

    752.89

    C43H52N4O8

    25 mg, 50 mg, 100 mg
  • PD-1/PD-L1-IN-34 [orb1944307]

    2924403-17-6

    565.1

    C35H33ClN2O3

    5 mg, 50 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information